A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer
- 1 March 1982
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 2 (1) , 93-99
- https://doi.org/10.1007/bf01805721
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A randomized attempt to increase the efficacy of cytotoxic chemotherapy in metastatic breast cancer by hormonal synchronizationJournal of Steroid Biochemistry, 1983
- Preliminary report on the efficacy of sequential methotrexate and 5-fluorouracil in advanced breast cancerCancer, 1981
- Combined effects of methotrexate and 5-fluoropyrimidine on human breast cancer cells in serum-free culturePublished by Elsevier ,1980
- Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancerPublished by Elsevier ,1980
- Estrogen Receptors and Responses to Chemotherapy and Hormonal Therapy in Advanced Breast CancerNew England Journal of Medicine, 1978
- The Relation between Estrogen Receptors and Response Rate to Cytotoxic Chemotherapy in Metastatic Breast CancerNew England Journal of Medicine, 1978
- Cytotoxicity of 5-fluoro-2'-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate.Proceedings of the National Academy of Sciences, 1978
- Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.1977
- Adjuvant postoperative chemotherapy with 5‐fluorouracil and methotrexate: Effect of schedule of administration on metastasis of 13762 mammary adenocarcinomaJournal of Surgical Oncology, 1977
- EFFECTS OF ESTROGENS AND ANTIESTROGENS ON HORMONE-RESPONSIVE HUMAN BREAST-CANCER IN LONG-TERM TISSUE-CULTURE1976